ALPHA TRIBE

Medicamen Biotech LimitedBoard Meeting, 13-02-2026: Outcome of Board Meeting

13-02-2026 | 04:06 pm

Medicamen Biotech's board approved Q3 & 9M consolidated financial results, with Q3 consolidated EPS at Rs. 1.21. Independent Directors Mr. Pande & Mr. Kumar completed their tenure. The board also reconstituted key committees.

No comments yet. Be the first to comment!

All announcements from Medicamen Biotech Limited